Glutaminases regulate glutathione and oxidative stress in cancer

JM Matés, JA Campos-Sandoval… - Archives of …, 2020 - Springer
Targeted therapies against cancer have improved both survival and quality of life of patients.
However, metabolic rewiring evokes cellular mechanisms that reduce therapeutic …

[HTML][HTML] Increased glutaminolysis marks active scarring in nonalcoholic steatohepatitis progression

K Du, SK Chitneni, A Suzuki, Y Wang, R Henao… - Cellular and molecular …, 2020 - Elsevier
Background & Aims Nonalcoholic steatohepatitis (NASH) occurs in the context of aberrant
metabolism. Glutaminolysis is required for metabolic reprograming of hepatic stellate cells …

[HTML][HTML] Targeted inhibition of glutamine metabolism enhances the antitumor effect of selumetinib in KRAS-mutant NSCLC

M Xia, X Li, Y Diao, B Du, Y Li - Translational Oncology, 2021 - Elsevier
Regulated by the tumor microenvironment, the metabolic network of the tumor is
reprogrammed, driven by oncogenes and tumor suppressor genes. The metabolic …

Imaging the rewired metabolism in lung cancer in relation to immune therapy

EAJ van Genugten, JAM Weijers, S Heskamp… - Frontiers in …, 2022 - frontiersin.org
Metabolic reprogramming is recognized as one of the hallmarks of cancer. Alterations in the
micro-environmental metabolic characteristics are recognized as important tools for cancer …

[18F](2S,4R)-4-Fluoroglutamine as a New Positron Emission Tomography Tracer in Myeloma

S Valtorta, D Toscani, M Chiu, A Sartori, A Coliva… - Frontiers in …, 2021 - frontiersin.org
The high glycolytic activity of multiple myeloma (MM) cells is the rationale for use of Positron
Emission Tomography (PET) with 18F-fluorodeoxyglucose ([18F] FDG) to detect both bone …

KRAS Mutation Detection with (2S,4R)-4-[18F]FGln for Noninvasive PDAC Diagnosis

S Liu, F Liu, X Hou, Q Zhang, Y Ren, H Zhu… - Molecular …, 2024 - ACS Publications
Pancreatic ductal adenocarcinoma (PDAC), which has a poor prognosis and nonspecific
symptoms and progresses rapidly, is the most common pancreatic cancer type. Inhibitors …

Dynamic PET/CT imaging of 18F-(2S, 4R)4-fluoroglutamine in healthy volunteers and oncological patients

X Xu, H Zhu, F Liu, Y Zhang, J Yang, L Zhang… - European Journal of …, 2020 - Springer
Purpose The purpose of this study was to compare dynamic 18 F-FGln PET/CT images of
healthy subjects and cancer patients and explore the best imaging phase for different …

Design, synthesis and evaluation of a novel glutamine derivative (2 S, 4 R)-2-amino-4-cyano-4-[18 F] fluorobutanoic acid

S Liu, R Wu, Y Sun, K Ploessl, Y Zhang, Y Liu… - New Journal of …, 2020 - pubs.rsc.org
Glutamine is an important source of nutrients for tumor proliferation. Designing new
glutamine-metabolizing PET imaging agents is useful for tumor diagnosis and treatment …

New Positron Emission Tomography Tracer in Myeloma

S Valtorta, D Toscani, M Chiu, A Sartori… - Insights in …, 2022 - books.google.com
Multiple myeloma (MM) is a hematological disease characterized by the accumulation of
malignant plasma cells (PC) into and, more rarely, outside the bone marrow (BM)(1). In the …

[PDF][PDF] Molecular Imaging Platform and Radiopharmaceutical Translational Research on Peking University Cancer Hospital

Z Yang, X Meng, X Guo, H Zhu - … : Festschrift in Honor of Richard P …, 2024 - library.oapen.org
Molecular Imaging Platform and Radiopharmaceutical Translational Research on Peking
University Cancer Hospital Page 354 367© The Author (s) 2024 V. Prasad (ed.), Beyond …